Document Detail


In vitro evaluation of a Folate-bovine serum albumin-doxorubicin conjugate.
MedLine Citation:
PMID:  20001219     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Doxorubicin (DOX) is one of the most effective anticancer drugs. However, its therapeutic effectiveness is greatly hampered by its dose limiting and cumulative cardiotoxic side effects. To overcome these limitations, bioconjugates of DOX were studied using bovine serum albumin (BSA) as a carrier to provide passive tumor targeting by the enhanced permeability and retention (EPR) effect. Folic acid, as an active targeting agent, was linked to BSA to increase the selectivity of the conjugate. In the present study, folate-targeted (Folate-BSA-DOX) conjugates were prepared. In the optimization process, we found that 30 mg of folic acid activated esters reacted with BSA at pH 9.8 for 1 h, the yield was maximum. The qualitative analysis of fluorescent experiments revealed that Folate-BSA-DOX can be specifically delivered to Hela cells and that this unique interaction can be blocked by 1 mM free folic acid. More importantly, the enhanced efficiency of uptake of Folate-BSA-DOX by Hela cells was coupled with the increase of the amount of the conjugate, the incubated time and the conjugated ratio of folic acid. Finally, the quantitative data obtained from the flow cytometry further verified the higher targeting and killing ability of Folate-BSA-DOX to folate receptor positive tumor cells than BSA-DOX.
Authors:
Xiaolan Qu; Chang Yang; Jing Zhang; Nan Ding; Yao Lu; Lei Huang; Guangya Xiang
Related Documents :
2401249 - Absolute bioavailability of phenytoin after 3-phosphoryloxymethyl phenytoin disodium (a...
1737759 - The folding of hirudin adopts a mechanism of trial and error.
9018449 - Folic acid in the prevention of birth defects.
12055379 - Establishing the shelf life of flexible colonoscopes.
10535399 - Effect of short-term medroxyprogesterone acetate on left ventricular mass: role of insu...
9808229 - Effects of folic acid and combinations of folic acid and vitamin b-12 on plasma homocys...
9574809 - Stereochemical aspects of styrene biotransformation.
196639 - Structural studies on the sialic acid polysaccharide antigen of escherichia coli strain...
18630909 - Acetal-derivatized dextran: an acid-responsive biodegradable material for therapeutic a...
Publication Detail:
Type:  In Vitro; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of drug targeting     Volume:  18     ISSN:  1029-2330     ISO Abbreviation:  J Drug Target     Publication Date:  2010 Jun 
Date Detail:
Created Date:  2010-05-06     Completed Date:  2010-08-05     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9312476     Medline TA:  J Drug Target     Country:  England    
Other Details:
Languages:  eng     Pagination:  351-61     Citation Subset:  IM    
Affiliation:
School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antineoplastic Agents / administration & dosage,  pharmacology*
Doxorubicin / administration & dosage,  pharmacology*
Drug Evaluation, Preclinical
Hela Cells
Humans
Serum Albumin, Bovine / administration & dosage*
Spectrophotometry, Ultraviolet
Chemical
Reg. No./Substance:
0/Antineoplastic Agents; 0/Serum Albumin, Bovine; 23214-92-8/Doxorubicin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Metabonomic profiling of diet-induced hyperlipidaemia in a rat model.
Next Document:  The inductive effect of BMP-4 protein on chondral-lineage differentiation and in-situ cartilage repa...